AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Redcare Pharmacy N.V.

Director's Dealing Mar 7, 2022

6219_dirs_2022-03-07_628cc991-3a7b-4455-8186-8d568e28ae3a.html

Director's Dealing

Open in Viewer

Opens in native device viewer

News Details

Directors’ Dealings | 7 March 2022 19:03

DGAP-DD: SHOP APOTHEKE EUROPE N.V. english

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

07.03.2022 / 19:03

The issuer is solely responsible for the content of this announcement.

1. Details of the person discharging managerial responsibilities / person closely associated

a) Name

Title:
First name: Marc Michael
Last name(s): Fischer

2. Reason for the notification

a) Position / status

Position: Member of the managing body

b) Initial notification

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a) Name

SHOP APOTHEKE EUROPE N.V.

b) LEI

529900JK6UXHY1YKZ082

4. Details of the transaction(s)

a) Description of the financial instrument, type of instrument, identification code

Type: Share
ISIN: NL0012044747

b) Nature of the transaction

Disposal

c) Price(s) and volume(s)

Price(s) Volume(s)
73.30 EUR 916,250.00 EUR

d) Aggregated information

Price Aggregated volume
73.3000 EUR 916,250.0000 EUR

e) Date of the transaction

2022-03-04; UTC+1

f) Place of the transaction

Outside a trading venue


07.03.2022 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.dgap.de


Language: English
Company: SHOP APOTHEKE EUROPE N.V.
Erik de Rodeweg 11-13
5975 WD Sevenum
Netherlands
Internet: www.shop-apotheke-europe.com
End of News DGAP News Service

show this

Talk to a Data Expert

Have a question? We'll get back to you promptly.